SHINECO - 9 Year Stock Price History | SISI

Historical daily share price chart and data for SHINECO since 2016 adjusted for splits and dividends. The latest closing stock price for SHINECO as of January 17, 2025 is 1.69.
  • The all-time high SHINECO stock closing price was 62380.58 on September 28, 2016.
  • The SHINECO 52-week high stock price is 117.55, which is 6855.6% above the current share price.
  • The SHINECO 52-week low stock price is 1.63, which is 3.6% below the current share price.
  • The average SHINECO stock price for the last 52 weeks is 20.98.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
SHINECO Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 1.8532 2.0750 2.0750 1.6700 1.6900 -62.69%
2024 22.3860 28.7280 108.2400 2.0400 4.5300 -83.24%
2023 107.9199 532.8000 532.8000 21.1680 27.0240 -95.27%
2022 455.3520 1327.2000 1327.2000 174.4800 571.1760 -64.16%
2021 1811.2571 724.8000 4459.1999 724.8000 1593.5999 117.35%
2020 945.2573 1350.0000 1576.8000 590.6880 733.2000 -45.89%
2019 1557.9690 1306.8000 3412.7999 944.5680 1354.9680 8.16%
2018 3050.5984 4881.5999 5507.9999 1144.8000 1252.8000 -74.78%
2017 7196.1095 8488.7998 11339.9998 3866.3999 4967.9999 -45.24%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.003B $0.010B
Shineco, Inc. is principally engaged in the production and distribution of herbal medicines, organic agricultural produce, specialized textiles and other health and well-being focused plant-based products primarily in China. Shineco, Inc. is headquartered in Beijing, China.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $74.844B 28.80
Chugai Pharmaceutical (CHGCY) Japan $70.231B 27.36
Takeda Pharmaceutical (TAK) Japan $41.110B 8.56
Sandoz Group AG (SDZNY) Switzerland $19.633B 0.00
Merck (MKKGY) Germany $18.831B 16.86
Astellas Pharma (ALPMY) Japan $17.264B 15.90
United Therapeutics (UTHR) United States $16.024B 15.76
Neurocrine Biosciences (NBIX) United States $14.505B 38.41
Summit Therapeutics (SMMT) United States $14.034B 0.00
Shionogi (SGIOY) Japan $12.114B 12.14
Orion OYJ (ORINY) Finland $7.195B 20.23
Stevanato Group S.p.A (STVN) Italy $6.920B 44.80
Madrigal Pharmaceuticals (MDGL) United States $6.404B 0.00
Corcept Therapeutics (CORT) United States $5.795B 43.90
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.456B 0.00
Grifols, S.A (GRFS) Spain $4.999B 0.00
Ionis Pharmaceuticals (IONS) United States $4.963B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.464B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.717B 12.31
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.559B 15.30
Recursion Pharmaceuticals (RXRX) United States $2.551B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.176B 0.00
Soleno Therapeutics (SLNO) United States $2.021B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.999B 0.00
Hypermarcas (HYPMY) Brazil $1.932B 0.00
Indivior (INDV) United States $1.606B 6.54
BioCryst Pharmaceuticals (BCRX) United States $1.543B 0.00
Evotec AG (EVO) Germany $1.456B 0.00
Dyne Therapeutics (DYN) United States $1.438B 0.00
Xencor (XNCR) United States $1.346B 0.00
Guardian Pharmacy Services (GRDN) United States $1.310B 0.00
Ocular Therapeutix (OCUL) United States $1.259B 0.00
ARS Pharmaceuticals (SPRY) United States $1.222B 0.00
Harrow (HROW) United States $1.206B 0.00
Ardelyx (ARDX) United States $1.187B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.147B 0.00
Collegium Pharmaceutical (COLL) United States $1.076B 5.87
Enliven Therapeutics (ELVN) United States $1.049B 0.00
Bioventus (BVS) United States $0.815B 25.74
Cronos Group (CRON) Canada $0.761B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.747B 0.00
Relay Therapeutics (RLAY) United States $0.747B 0.00
USANA Health Sciences (USNA) United States $0.648B 12.02
Ironwood Pharmaceuticals (IRWD) United States $0.586B 0.00
Elite Pharmaceuticals (ELTP) United States $0.526B 0.00
Verve Therapeutics (VERV) United States $0.520B 0.00
Savara (SVRA) United States $0.503B 0.00
Altimmune (ALT) United States $0.488B 0.00
ProKidney (PROK) United States $0.484B 0.00
Xeris Biopharma Holdings (XERS) United States $0.477B 0.00
Tourmaline Bio (TRML) United States $0.462B 0.00
OmniAb (OABI) United States $0.453B 0.00
Akebia Therapeutics (AKBA) United States $0.452B 0.00
Siga Technologies (SIGA) United States $0.444B 5.19
Esperion Therapeutics (ESPR) United States $0.435B 0.00
Zevra Therapeutics (ZVRA) United States $0.430B 0.00
Oruka Therapeutics (ORKA) United States $0.429B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.422B 0.00
Organogenesis (ORGO) United States $0.420B 0.00
KalVista Pharmaceuticals (KALV) United States $0.410B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.355B 143.79
Korro Bio (KRRO) United States $0.347B 0.00
Aldeyra Therapeutics (ALDX) United States $0.288B 0.00
Aquestive Therapeutics (AQST) United States $0.283B 0.00
Nature's Sunshine Products (NATR) United States $0.264B 15.68
Heron Therapeutics (HRTX) United States $0.248B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.247B 0.00
Avita Medical (RCEL) United States $0.227B 0.00
Profound Medical (PROF) Canada $0.221B 0.00
Larimar Therapeutics (LRMR) United States $0.213B 0.00
4D Molecular Therapeutics (FDMT) United States $0.212B 0.00
MediWound (MDWD) Israel $0.190B 0.00
Inhibikase Therapeutics (IKT) United States $0.189B 0.00
CytoDyn (CYDY) United States $0.185B 0.00
Aclaris Therapeutics (ACRS) United States $0.184B 0.00
Acrivon Therapeutics (ACRV) United States $0.180B 0.00
VAXART, INC (VXRT) United States $0.168B 0.00
Lyell Immunopharma (LYEL) United States $0.168B 0.00
Lexeo Therapeutics (LXEO) United States $0.168B 0.00
Nektar Therapeutics (NKTR) United States $0.165B 0.00
Silence Therapeutics (SLN) United Kingdom $0.153B 0.00
Jupiter Neurosciences (JUNS) United States $0.146B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.145B 0.00
Nanobiotix S.A (NBTX) France $0.143B 0.00
Telomir Pharmaceuticals (TELO) United States $0.139B 0.00
Champions Oncology (CSBR) United States $0.135B 0.00
Cassava Sciences (SAVA) United States $0.132B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.111B 0.00
Inotiv (NOTV) United States $0.111B 0.00
Achieve Life Sciences (ACHV) Canada $0.106B 0.00
ElectroCore (ECOR) United States $0.104B 0.00
Cardiol Therapeutics (CRDL) Canada $0.099B 0.00
Metagenomi (MGX) United States $0.098B 0.00
Protara Therapeutics (TARA) United States $0.094B 0.00
Pyxis Oncology (PYXS) United States $0.089B 0.00
Fractyl Health (GUTS) United States $0.087B 0.00
Arch Biopartners (ACHFF) Canada $0.085B 0.00
Karyopharm Therapeutics (KPTI) United States $0.083B 0.00
Regulus Therapeutics (RGLS) United States $0.081B 0.00
Assertio Holdings (ASRT) United States $0.079B 20.68
Galectin Therapeutics (GALT) United States $0.078B 0.00
ESSA Pharma (EPIX) Canada $0.078B 0.00
Century Therapeutics (IPSC) United States $0.077B 0.00
Journey Medical (DERM) United States $0.076B 0.00
Context Therapeutics (CNTX) United States $0.076B 0.00
Vivani Medical (VANI) United States $0.071B 0.00
PMV Pharmaceuticals (PMVP) United States $0.071B 0.00
Avalo Therapeutics (AVTX) United States $0.070B 0.00
Mural Oncology (MURA) Ireland $0.068B 0.00
AleAnna (ANNA) United States $0.065B 0.00
Unicycive Therapeutics (UNCY) United States $0.064B 0.00
OptiNose (OPTN) United States $0.064B 0.00
Gain Therapeutics (GANX) United States $0.060B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.059B 0.00
Prelude Therapeutics (PRLD) United States $0.058B 0.00
FibroGen (FGEN) United States $0.058B 0.00
Rafael Holdings (RFL) United States $0.050B 0.00
NRx Pharmaceuticals (NRXP) United States $0.049B 0.00
AlloVir (ALVR) United States $0.047B 0.00
Nutriband (NTRB) United States $0.046B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.044B 0.00
SCYNEXIS (SCYX) United States $0.043B 0.00
Iterum Therapeutics (ITRM) Ireland $0.042B 0.00
CASI Pharmaceuticals (CASI) China $0.041B 0.00
Scienture Holdings (SCNX) United States $0.040B 0.00
Tempest Therapeutics (TPST) United States $0.040B 0.00
VYNE Therapeutics (VYNE) United States $0.040B 0.00
BioVie (BIVI) United States $0.040B 0.00
Surrozen (SRZN) United States $0.039B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.036B 0.00
Incannex Healthcare (IXHL) Australia $0.034B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.031B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.030B 0.00
Citius Pharmaceuticals (CTXR) United States $0.028B 0.00
Vivos Therapeutics (VVOS) United States $0.028B 0.00
DURECT (DRRX) United States $0.026B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.026B 0.00
Natural Alternatives (NAII) United States $0.026B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Lipocine (LPCN) United States $0.023B 0.00
Traws Pharma (TRAW) United States $0.022B 0.00
Mannatech (MTEX) United States $0.021B 0.00
Cosmos Health (COSM) United States $0.020B 0.00
MEI Pharma (MEIP) United States $0.019B 0.00
Carisma Therapeutics (CARM) United States $0.018B 0.00
GlycoMimetics (GLYC) United States $0.017B 0.00
PolyPid (PYPD) Israel $0.016B 0.00
Minerva Neurosciences (NERV) United States $0.016B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
TherapeuticsMD (TXMD) United States $0.012B 0.00
Biomerica (BMRA) United States $0.012B 0.00
Nuvilex (PMCB) United States $0.012B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.012B 0.00
Talphera (TLPH) United States $0.011B 0.00
Relmada Therapeutics (RLMD) United States $0.011B 0.00
Jaguar Animal Health (JAGX) United States $0.010B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.009B 0.00
Ainos (AIMD) United States $0.009B 0.00
Klotho Neurosciences (KLTO) United States $0.009B 0.00
Indaptus Therapeutics (INDP) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
BioLineRx (BLRX) Israel $0.008B 0.00
Dominari Holdings (DOMH) United States $0.008B 0.00
Conduit Pharmaceuticals (CDT) United States $0.007B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.007B 0.00
Redhill Biopharma (RDHL) Israel $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Viracta Therapeutics (VIRX) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
SciSparc (SPRC) Israel $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Phio Pharmaceuticals (PHIO) United States $0.004B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.10
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
Bio-Path Holdings (BPTH) United States $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Clearmind Medicine (CMND) Canada $0.003B 0.00
TransCode Therapeutics (RNAZ) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00